Furthermore, the number of CD4+ and CD8+ T cells was pointedly augmented in the treated tumor‐bearing BALB/c mice.[162] It has been revealed that following systemic administration of oncolytic virus M1, the number of infiltrated Tregs in the TME was increased in melanoma and prostatic tumor models. This evidence concerns the gene CD8A and neoplasm.